Stock NEURALSTEM, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Neuralstem, Inc. Nyse

Equities

US64127R3021

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for Neuralstem, Inc.
Apr. 23 Palisade Bio Collaborating With Strand Life Sciences on Ulcerative Colitis Therapy MT
Apr. 23 Palisade Bio, Inc. Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach
AQ
Palisade Bio Collaborating With Strand Life Sciences on Ulcerative Colitis Therapy
MT
Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach
AQ
Palisade Bio, Inc. Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach
CI
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 in Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients Stool
AQ
Sector Update: Health Care Stocks Edge Up Tuesday Afternoon
MT
Palisade Bio Shows Bioactivation of PALI-2108 in Study; Shares Rise
MT
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ Stool
AQ
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients? Stool
CI
Palisade Bio to Participate in the Virtual Investor Lunch Break Event
AQ
Palisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis™
AQ
Reverse Split: 1 of 15
FA
Palisade Bio Announces 1-for-15 Reverse Stock Split
AQ
North American Morning Briefing : Stocks Seen -2-
DJ
Palisade Bio Reports Year End 2023 Financial Results and Provides Corporate Update
AQ
Palisade Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Palisade Bio, Inc. Announces Resignation of Mary Ann Gray as Member of the Board
CI
Palisade Bio to Present at Digestive Disease Week (DDW) 2024
AQ
Palisade Bio Names Donald Williams as Chairman
MT
Palisade Bio Provides Corporate Update and Reiterates Guidance
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SNCA Stock
  4. Stock
  5. News Neuralstem, Inc.